Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Binimetinib + Panitumumab in mCRC
NCT01927341Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of binimetinib in metastatic colorectal cancer (mCRC), sponsored by Pfizer. Started Nov 2013; status: completed.
02
Drugs
binimetinib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01927341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01927341.